Veena Upadhyay
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Veena Upadhyay.
Tetrahedron Letters | 1995
Peter E. Maligres; Veena Upadhyay; Kai Rossen; Steven J. Cianciosi; Robert Purick; Kan K. Eng; Robert A. Reamer; David Askin; Ralph P. Volante; Paul J. Reider
Abstract Reaction of 2-alkyl-4-enamides 2, 9–15 with NIS and aqueous sodium bicarbonate results in the diastereoselective formation of the corresponding iodohydrins 3, 16–22 with essentially no iodolactone by-product. This methodology has been successfully employed for the synthesis of the epoxide intermediate 4 of the orally active Merck HIV-1 protease inhibitor L-735,524.
Tetrahedron | 1997
Peter E. Maligres; Ioannis N. Houpis; Kai Rossen; Audrey Molina; Jess W. Sager; Veena Upadhyay; Kenneth M. Wells; Robert A. Reamer; Joseph E. Lynch; David Askin; Ralph P. Volante; Paul J. Reider; Peter G. Houghton
Abstract The preparation of the Merck Growth Hormone Secretagogue; MK-677 is described. A Fischer indole/reduction based strategy provides the novel spiroindoline nucleus of this potent compound. This optimized sequence necessitates the isolation of only one intermediate 10 and provides MK-677 in 48% overall yield from isonipecotic acid 3.
Tetrahedron | 1996
Peter E. Maligres; Steven A. Weissman; Veena Upadhyay; Steven J. Cianciosi; Robert A. Reamer; Robert Purick; Jess W. Sager; Kai Rossen; Kan K. Eng; David Askin; Ralph P. Volante; Paul J. Reider
Abstract Reaction of 2-alkyl-4-enamides with 1 + and aqueous sodium bicarbonate results in the diastereoselective formation of the corresponding iodohydrins with essentially no iodolactone by-product. The reaction appears to proceed through a cyclic imidate type intermediate. This methodology has been successfully employed for the synthesis of the epoxide intermediate of the orally active HIV-1 protease inhibitor MK-639 (indinavir sulfate).
Journal of Bioscience and Bioengineering | 1999
Michel Chartrain; Peter E. Maligres; Deborah Cohen; Veena Upadhyay; Victor Pecore; David Askin; Randolph Greasham
A limited screen of several commercially-available and internally-produced lipases and esterases identified porcine liver esterase as a suitable biocatalyst for the enantioselective hydrolysis of a diester into its (S)-ester acid with high optical purity (99%). This (S)-ester acid is a precursor to an experimental growth hormone secretagogue. After identifying xanthan gum as the best emulsifier and optimizing the reaction conditions, hydrolysis rates of 1 g/l.h and final (S)-ester acid (ee > 99%) titers of about 8.5 g/l were routinely achieved. This process supported the production of preparative amounts of optically pure (S)-ester (ee > 99%) with a high reaction yield of 82%. Upon purification, the (S)-ester was successfully used in the subsequent synthetic steps to yield the growth hormone secretagogue.
Synthesis | 1999
Zhen Li; Veena Upadhyay; Ann E. DeCamp; Lisa DiMichele; Paul J. Reider
Journal of Organic Chemistry | 2005
John Limanto; Ali Shafiee; Paul N. Devine; Veena Upadhyay; Richard Desmond; Bruce R. Foster; Donald R. Gauthier; Robert A. Reamer; Ralph P. Volante
Tetrahedron-asymmetry | 2005
Ali Shafiee; Veena Upadhyay; Edward G. Corley; Mirlinda Biba; Dalian Zhao; Jean-Francois Marcoux; Kevin R. Campos; Michel Journet; Anthony O. King; Rob Larsen; Edward J. J. Grabowski; Ralph P. Volante; Richard D. Tillyer
Archive | 1995
David Askin; Kan K. Eng; Peter E. Maligres; Paul J. Reider; Kai Rossen; Ralph P. Volante; Veena Upadhyay
Journal of Organic Chemistry | 1998
Peter E. Maligres; Michel M. Chartrain; Veena Upadhyay; Deborah Cohen; Robert A. Reamer; David Askin; Ralph P. Volante; Paul J. Reider
Archive | 1996
David Askin; Peter E. Maligres; Paul J. Reider; Kai Rossen; Jess W. Sager; Veena Upadhyay; Ralph P. Volante; Kenneth M. Wells